Pain Relief and Safety of Microwave Ablation Combined with Percutaneous Vertebroplasty for Vertebral Metastasis: A Pilot Study

Abstract

Background We investigate the pain relief and safety of microwave ablation (MWA) combined with percutaneous vertebroplasty (PVP) in the treatment of metastatic vertebral tumors.

Methods This prospective pilot study enrolled patients with metastatic vertebral tumors treated between January 2018 and October 2019. The participants were randomized to the PVP and MWA + PVP groups. Clinical parameters, pain visual analog scale (VAS), analgesic use scores (AUS), and quality-of-life score (QLS) were compared between groups.

Results Sixty-seven participants were enrolled (PVP: n = 35; MWA + PVP: n = 32). There were no differences in bone cement injection volume, extravasation, and X-ray exposure time between the two groups (p > 0.05), but treatment costs were higher for the MWA + PVP group (26,418 ± 194 vs. 15,606 ± 148 yuan; p < 0.05). There were no significant improvements in VAS from baseline to 24 hours, 72 hours, 7 days, 1 month, and 3 months in the two groups (p > 0.05); at 6 and 12 months after the operation, the improvement from baseline was significant in the two groups (p < 0.05). The VAS was lower at 6 months (2.7 ± 0.7 vs. 3.2 ± 0.7) and 12 months (3.5 ± 0.8 vs. 4.0 ± 0.7) in the MWA + PVP group (both p < 0.01 vs. PVP). The AUS and QLS were improved with PVP at 6 and 12 months (p < 0.05) and with MWA + PVP at 12 months (p < 0.05). The AUS was lower at 6 and 12 months in the MWA + PVP group (p < 0.05 vs. PVP).

Conclusion MWA combined with PVP might be a safe and effective palliative treatment for pain from metastatic vertebral tumors.

Keywords

vertebra - metastasis - microwave ablation - percutaneous vertebroplasty - pain

Publikationsverlauf

Eingereicht: 14. Februar 2022

Angenommen: 28. Juni 2022

Artikel online veröffentlicht:
09. Dezember 2022

• References

• 1 Mansoorinasab M, Abdolhoseinpour H. A review and update of vertebral fractures due to metastatic tumors of various sites to the spine: percutaneous vertebroplasty. Interv Med Appl Sci 2018; 10 (01) 1-6
• 2 Ke J, Ouyang YQ, Redding SR. Family-centered breastfeeding education to promote primiparas' exclusive breastfeeding in China. J Hum Lact 2018; 34 (02) 365-378
• 3 National Collaborating Centre for Cancer, National Institute for Health and Clinical Excellence. Guidance. Metastatic Spinal Cord Compression: Diagnosis and Management of Patients at Risk of or with Metastatic Spinal Cord Compression. Cardiff, UK: National Collaborating Centre for Cancer; 2008
• 4 White BD, Stirling AJ, Paterson E, Asquith-Coe K, Melder A. Guideline Development Group. Diagnosis and management of patients at risk of or with metastatic spinal cord compression: summary of NICE guidance. BMJ 2008; 337: a2538
• 5 Delank KS, Wendtner C, Eich HT, Eysel P. The treatment of spinal metastases. Dtsch Arztebl Int 2011; 108 (05) 71-79 , quiz 80
• 6 Nater A, Sahgal A, Fehlings M. Management: spinal metastases. Handb Clin Neurol 2018; 149: 239-255
• 7 Choi SH, Koo JW, Choe D, Kang CN. The incidence and management trends of metastatic spinal tumors in south korea: a nationwide population-based study. Spine 2020; 45 (14) E856-E863
• 8 Wright E, Ricciardi F, Arts M. et al. Metastatic spine tumor epidemiology: comparison of trends in surgery across two decades and three continents. World Neurosurg 2018; 114: e809-e817
• 9 Patel A, Petrone B, Carter KR. Percutaneous Vertebroplasty and Kyphoplasty. Treasure Island, FL: StatPearls Publishing; 2021
• 10 Beall DP, Braswell JJ, Martin HD, Stapp AM, Puckett TA, Stechison MT. Technical strategies and anatomic considerations for parapedicular access to thoracic and lumbar vertebral bodies. Skeletal Radiol 2007; 36 (01) 47-52
• 11 Genev IK, Tobin MK, Zaidi SP, Khan SR, Amirouche FML, Mehta AI. Spinal compression fracture management: a review of current treatment strategies and possible future avenues. Global Spine J 2017; 7 (01) 71-82
• 12 Medical Advisory Secretariat. Percutaneous vertebroplasty for treatment of painful osteoporotic vertebral compression fractures: an evidence-based analysis. Ont Health Technol Assess Ser 2010; 10 (19) 1-45
• 13 Saliou G, Kocheida M, Lehmann P. et al. Percutaneous vertebroplasty for pain management in malignant fractures of the spine with epidural involvement. Radiology 2010; 254 (03) 882-890
• 14 Barragán-Campos HM, Le Faou AL, Rose M. et al. Percutaneous vertebroplasty in vertebral metastases from breast cancer: interest in terms of pain relief and quality of life. Interv Neuroradiol 2014; 20 (05) 591-602
• 15 Ko YK, Kim YH. Percutaneous vertebroplasty for painful spinal metastasis: a good option for better quality of life. Korean J Anesthesiol 2013; 64 (03) 201-203
• 16 Cianfoni A, Massari F, Ewing S, Persenaire M, Rumboldt Z, Bonaldi G. Combining percutaneous pedicular and extrapedicular access for tumor ablation in a thoracic vertebral body. Interv Neuroradiol 2014; 20 (05) 603-608
• 17 Lu CW, Shao J, Wu YG. et al. Which combination treatment is better for spinal metastasis: percutaneous vertebroplasty with radiofrequency ablation, 125I seed, zoledronic acid, or radiotherapy?. Am J Ther 2019; 26 (01) e38-e44
• 18 Li T, Li J, Wang Z, Liu B, Han D, Wang P. A preliminary comparative clinical study of vertebroplasty with multineedle or single-needle interstitial implantation of (125)I seeds in the treatment of osteolytic metastatic vertebral tumors. J Neurosurg Spine 2014; 20 (04) 430-435
• 19 Yang Z, Zhang Y, Xu D. et al. Percutaneous vertebroplasty combined with interstitial implantation of 125I seeds in banna mini-pigs. World J Surg Oncol 2013; 11: 46
• 20 Zhao W, Wang H, Hu JH. et al. Palliative pain relief and safety of percutaneous radiofrequency ablation combined with cement injection for bone metastasis. Jpn J Clin Oncol 2018; 48 (08) 753-759
• 21 Lubner MG, Brace CL, Hinshaw JL, Lee Jr FT. Microwave tumor ablation: mechanism of action, clinical results, and devices. J Vasc Interv Radiol 2010; 21 (8, Suppl): S192-S203
• 22 Simon CJ, Dupuy DE, Mayo-Smith WW. Microwave ablation: principles and applications. Radiographics 2005; 25 (Suppl. 01) S69-S83
• 23 Poggi G, Tosoratti N, Montagna B, Picchi C. Microwave ablation of hepatocellular carcinoma. World J Hepatol 2015; 7 (25) 2578-2589
• 24 Healey TT, March BT, Baird G, Dupuy DE. Microwave ablation for lung neoplasms: a retrospective analysis of long-term results. J Vasc Interv Radiol 2017; 28 (02) 206-211
• 25 Cazzato RL, de Rubeis G, de Marini P. et al. Percutaneous microwave ablation of bone tumors: a systematic review. Eur Radiol 2021; 31 (05) 3530-3541
• 26 Kinczewski L. Microwave ablation for palliation of bone metastases. Clin J Oncol Nurs 2016; 20 (03) 249-252
• 27 Pusceddu C, Sotgia B, Fele RM, Ballicu N, Melis L. Combined microwave ablation and cementoplasty in patients with painful bone metastases at high risk of fracture. Cardiovasc Intervent Radiol 2016; 39 (01) 74-80
• 28 Kastler A, Alnassan H, Aubry S, Kastler B. Microwave thermal ablation of spinal metastatic bone tumors. J Vasc Interv Radiol 2014; 25 (09) 1470-1475
• 29 Sagoo NS, Haider AS, Rowe SE. et al. Microwave ablation as a treatment for spinal metastatic tumors: a systematic review. World Neurosurg 2021; 148: 15-23
• 30 Westbroek EM, Goodwin ML, Hui F, Khan MA, Sciubba DM. Thermal injury to spinal cord, a rare complication of percutaneous microwave spine tumor ablation: case report. J Clin Neurosci 2019; 64: 50-54
• 31 Khan MA, Deib G, Deldar B, Patel AM, Barr JS. Efficacy and safety of percutaneous microwave ablation and cementoplasty in the treatment of painful spinal metastases and myeloma. AJNR Am J Neuroradiol 2018; 39 (07) 1376-1383
• 32 Tokuhashi Y, Matsuzaki H, Oda H, Oshima M, Ryu J. A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine 2005; 30 (19) 2186-2191
• 33 Fu M, Zhong Q, Chen XR, Yang J, Wei J. Clinic discussion of percutaneous multi-targets vertebroplasty under CT guidance for treatment of vertebral metastsic tumor pain. Chin J Pain Med 2018; 24: 841-846
• 34 Wegmann K, Gundermann S, Siewe J, Eysel P, Delank KS, Sobottke R. Correlation of reduction and clinical outcome in patients with degenerative spondylolisthesis. Arch Orthop Trauma Surg 2013; 133 (12) 1639-1644
• 35 Sioutos PJ, Arbit E, Meshulam CF, Galicich JH. Spinal metastases from solid tumors. Analysis of factors affecting survival. Cancer 1995; 76 (08) 1453-1459
• 36 Perrin RG. Metastatic tumors of the axial spine. Curr Opin Oncol 1992; 4 (03) 525-532
• 37 Dalbayrak S, Onen MR, Yilmaz M, Naderi S. Clinical and radiographic results of balloon kyphoplasty for treatment of vertebral body metastases and multiple myelomas. J Clin Neurosci 2010; 17 (02) 219-224
• 38 Corniola MV, Stienen MN, Joswig H. et al. Correlation of pain, functional impairment, and health-related quality of life with radiological grading scales of lumbar degenerative disc disease. Acta Neurochir (Wien) 2016; 158 (03) 499-505
• 39 Tharmalingam S, Chow E, Harris K, Hird A, Sinclair E. Quality of life measurement in bone metastases: a literature review. J Pain Res 2008; 1: 49-58
• 40 Botsa E, Mylona S, Koutsogiannis I, Koundouraki A, Thanos L. CT image guided thermal ablation techniques for palliation of painful bone metastases. Ann Palliat Med 2014; 3 (02) 47-53
• 41 George E, Liacouras P, Lee TC, Mitsouras D. 3D-printed patient-specific models for CT- and MRI-guided procedure planning. AJNR Am J Neuroradiol 2017; 38 (07) E46-E47
• 42 Wu L, Fan J, Yuan Q, Zhang X, Hu M, Zhang K. Computed tomography-guided microwave ablation combined with percutaneous vertebroplasty for treatment of painful high thoracic vertebral metastases. Int J Hyperthermia 2021; 38 (01) 1069-1076
• 43 Pusceddu C, De Francesco D, Melis L, Ballicu N, Fancellu A. The role of a navigational radiofrequency ablation device and concurrent vertebral augmentation for treatment of difficult-to-reach spinal metastases. Curr Oncol 2021; 28 (05) 4004-4015
• 44 Deib G, Deldar B, Hui F, Barr JS, Khan MA. Percutaneous microwave ablation and cementoplasty: clinical utility in the treatment of painful extraspinal osseous metastatic disease and myeloma. AJR Am J Roentgenol 2019; 212: 1377-1384